Additionally, many imaging sites with DXA technology do not have or wish to use the additional body composition programming, given staff and time constraints
As of June 2026, retatrutide is not FDA-approved
By weeks 5-8, strength should be holding steady or increasing while body weight drops - which means you're losing fat and keeping muscle
However, early translational efforts were complicated by overlap between metabolic and neurobehavioral effects, raising concerns about central nervous system liabilities
Nature explains that, in trials, the drug has been found to reduce weight by an average of 24% over 48 weeks, making it a benchmark for weight-loss drugs
The study found GLP-1 (7-36) to be more potent than GIP in stimulating the release of insulin